MUC1 and neoplasm: To enhance NK cell tumor specificity, we generated a MUC1.BiKE to provide antigen engagement to these NK cells, and confirmed that the MUC1.BiKE increased NK cell killing of SUM-159 cells to 69% lysis compared to 43% at baseline (Figure 2F).